B-Lymphocyte Antigen CD20 (MS4A1) Antibody

494€ (200 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx413275
tested applications
IHC, FCM
Description
B-Lymphocyte Antigen CD20 (CD20) Antibody is a Mouse Monoclonal antibody against B-Lymphocyte Antigen CD20 (CD20).
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | B-Lymphocyte Antigen CD20 (MS4A1) |
Host | Mouse |
Reactivity | Human |
Recommended Dilution | Validated in IHC-F. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG2b |
Purification | Purified |
Size 1 | 200 µg |
Form | Liquid |
Tested Applications | IHC, FCM |
Buffer | PBS. Contains sodium azide. |
Availability | Shipped within 3-7 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | P11836 |
Alias | B1,S7,Bp35,CD20,FMC7,CVID5,LEU-16,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1,Leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1 |
Background | Antibody anti-MS4A1 |
Status | RUO |
Note | Concentration: 1 mg/ml - |
Descripción
MS4A1, also known as CD20, is a membrane-bound protein that plays a key role in the regulation of B-cell development, activation, and differentiation. It is predominantly expressed on the surface of B lymphocytes from the pre-B cell stage through to the mature B cell stage, and its expression is lost once B cells differentiate into plasma cells. CD20 is widely studied for its role in both normal immune function and its involvement in a variety of B-cell-related diseases, including non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), and autoimmune diseases. MS4A1 is a member of the membrane-spanning 4A (MS4A) family of proteins, which includes several proteins with similar structural features, although their specific functions may differ across cell types and tissues. CD20 has become a major therapeutic target, particularly in B-cell depletion therapies, due to its restricted expression pattern and its role in the immune response. The development of anti-CD20 monoclonal antibodies, such as rituximab, has revolutionized the treatment of B-cell malignancies and certain autoimmune conditions.
Related Products

Human MS4A1(B-lymphocyte antigen CD20) ELISA Kit
Ver Producto
Mouse CD20 (B-lymphocyte antigen CD20) ELISA Kit
Ver Producto
anti- CD20 antibody
CD20 is a 33-37 kDa transmembrane phosphoprotein. CD20 is a B-lymphocyte surface molecule that is widely expressed during B-cell ontogeny, from early pre-B-cell developmental stages until final differentiation into plasma cells. CD20 functions as calcium-permeable cation channel. It is involved in the regulation of B-cell activation and proliferation. CD20 serves as a useful target for antibody-mediated therapeutic depletion of B-cells.
Ver Producto